News

Amplia Therapeutics (ASX:ATX) is undertaking a placement, director placement and entitlement offer to raise up to $13 million, with interim data from the ACCENT trial supporting its continuation.

Priceline Pharmacy has unveiled a new visual identity that the company says reflects a refreshed brand strategy focused on providing health expertise and a beauty experience.

"The vaccine rollout was slow to start, hampered by logistical challenges, a lack of vaccine supply, and concerns about rare but serious side effects. However, it picked up pace by mid-2021 as the eastern states experienced a growing wave of infections caused by the Delta variant," found the report.

Boehringer Ingelheim's Dirk Otto has been promoted to head of strategy and development globally and will relocate to the company’s global headquarters in Germany at the end of the year.

The biopharmaceutical industry can now rest assured that politicians will never again lecture it about its relationships with clinicians and patient organisations.

The 2025-26 Budget is expected to be announced in late March. It will likely include several new PBS listings that will be implemented over the following months, including during the caretaker period.

Australian women in every state and territory can now access treatment for uncomplicated urinary tract infections without a prescription at a community pharmacy.

"For several years, there has been concern that there are more cancer medicines available for those living with cancer in Australia than in Aotearoa New Zealand," aid the chief executive of Cancer Control Agency, Rami Rahal.

In developing any response, it is critical to place the deferral of these submissions in the broader context of a long-term move to reform the process so that therapies are ordered from high priority to low priority.

In formulating and implementing the deferral plan, you can be sure that officials would have anticipated and planned for the criticism and Friday's meeting.

Medicines Australia met with senior health department officials on Friday to discuss its members' concerns over the plan to defer the evaluation and consideration of almost 50 submissions to the March PBAC meeting.

The Australian Patients Association has announced the appointment of Lisa Robins as its new chief executive officer.